Home / Companies / TG Therapeutics, Inc. / 11 Jun 2026
TG Therapeutics, Inc.: meeting of 11 Jun 2026
Votes reported on Form N-PX, item by item
472 Form N-PX filers reported votes at the TG Therapeutics, Inc. meeting of 11 Jun 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
6 nominees; 44.5% of reported votes for; 121 filers withheld from or voted against at least one nominee.
1,853 vote records from 144 filers. 73 of the 141 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
711 vote records from 471 filers. 309 of the 444 filers that marked the item either way voted against management. 27 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
313 vote records from 144 filers. 3 of the 141 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | Against * | For |
| BlackRock and iShares | For | Against * | For |
| Fidelity | For | Against * | For |
| Dimensional | Abstain or withhold * | Against * | For |
| State Street and SPDR | For | Against * | For |
| American Century | Abstain or withhold * | Against * | For |
| Franklin Templeton | Abstain or withhold * | Against * | For |
| Invesco | For | Against * | For |
| Equitable | Abstain or withhold * | Against * | For |
| Charles Schwab | Abstain or withhold * | Against * | For |
| Nuveen and TIAA | Split or no vote | For | For |
| ProShares and ProFunds | Abstain or withhold * | Against * | For |
| John Hancock and Manulife | Abstain or withhold * | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | Against * | For |
| J.P. Morgan | Abstain or withhold * | Against * | For |
| Goldman Sachs | For | For | For |
| WisdomTree | Abstain or withhold * | Against * | For |
| PGIM and Prudential | For | Against * | For |
| Jackson National funds | Abstain or withhold * | Against * | For |
| Northern Trust and FlexShares | For | Against * | For |
| SEI | Abstain or withhold * | Against * | For |
| T. Rowe Price | Abstain or withhold * | Against * | For |
| Thrivent | Abstain or withhold * | Against * | For |
| Lincoln Financial | For | Against * | For |
| Voya | For | Against * | For |
| First Trust | Abstain or withhold * | Against * | For |
| Russell Investments | Abstain or withhold * | Against * | For |
| Nationwide | For | Against * | For |
| Victory Capital | Abstain or withhold * | Against * | For |
| Brighthouse Funds | Abstain or withhold * | Against * | For |
| Guggenheim and Rydex | Abstain or withhold * | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | Abstain or withhold * | Against * | For |
| Principal | Abstain or withhold * | Against * | For |
| Pacific Life funds | For | Against * | For |
| Global X | Abstain or withhold * | Against * | For |
| Transamerica | Abstain or withhold * | Against * | For |
| Federated Hermes | Abstain or withhold * | Against * | For |
| AllianceBernstein | No report | Against * | No report |
| DWS | Abstain or withhold * | Against * | For |
| Allspring | Abstain or withhold * | Against * | For |
| MassMutual | No report | For | No report |
| Janus Henderson | No report | Against * | No report |
| Neuberger Berman | No report | Against * | No report |
| Natixis and Loomis Sayles | No report | Against * | No report |
| Baird | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the TG Therapeutics, Inc. meeting?
472 Form N-PX filers reported votes at the meeting of 11 Jun 2026. On say-on-pay, 309 of 444 voted against management (69.6%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by TG Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for TG Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing TG Therapeutics, Inc. with a meeting date within three days of 11 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.